19 October 2026

strategyland.uk

CVS Group PLC (CVSG)

Rank #90 of 280 - Healthcare - UK Equities

Home/Stocks/Healthcare

CVS Group PLC

CVSG.L·Healthcare·Market Cap £790m

Rank #90 of 280

Quantitative Model · 280 Stocks Analysed

£11.73

-8.64% YTD

52W: £10.62 - £16.48

Factor Analysis Summary

Editorial assessment generated from CVS Group PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, CVS Group PLC (CVSG.L) currently holds an overall rank of #90 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include asset efficiency, where it demonstrates highly efficient capital deployment, converting assets into revenue and returns effectively; liquidity, where it demonstrates exceptional market liquidity with deep trading volumes that support efficient entry and exit; and technical (RSI 31.2), where it demonstrates generally favourable technical indicators with price holding above key moving averages.

Areas requiring attention include valuation (P/E 48.1, dividend yield 442.1%), where the stock appears richly priced on forward earnings and cash flow metrics, as well as market trading, where low relative volume or adverse volatility patterns may deter momentum-oriented investors.

Within the Healthcare sector, CVS Group PLC sits at composite rank #90, trailing the Healthcare peer average (rank 83). Among 7 Healthcare names in our coverage, it ranks above 3 peers and below 3.

The composite profile is weighed down by 4 below-average factor scores, with valuation (rank 211/280) representing the most significant drag on its #90 overall standing.

Strongest Factors

Asset Efficiency — Rank 34/280 (top quartile)
Liquidity — Rank 60/280 (top quartile)
Technical — Rank 78/280 (above average)

Weakest Factors

Valuation — Rank 211/280 (below average)
Market Trading — Rank 200/280 (below average)

Score Analysis

CVS Group PLC is ranked #90 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

139/280

Average Score

Liquidity

Excellent60/280

Valuation

Weak211/280

Profitability

Weak200/280

Solvency

Weak191/280

Asset Efficiency

Excellent34/280

Mkt Trading

Weak200/280

Technical

Good78/280

1. Liquidity

Score: 60/280

How liquid is CVSG and can it meet its short-term obligations?

0/6

liquidity criteria met

Metric

Sector Range

Value

Rank

✗

Quick Ratio

1.0 - 2.5

0.94xRank 77/280

Range: 1.0 - 2.5Rank 77/280

✗

Current Ratio

1.5 - 2.5

1.18xRank 144/280

Range: 1.5 - 2.5Rank 144/280

✗

TTM Operating Cash Flow

0.8 - 1.5

0.57xRank 95/280

Range: 0.8 - 1.5Rank 95/280

–

Liquidity Coverage Ratio

N/A

Range: N/A

✗

Intangible Asset Ratio

5 - 20

0.15xRank 26/280

Range: 5 - 20Rank 26/280

✗

Cash-to-Debt Ratio

0.4 - 1.2

0.06xRank 220/280

Range: 0.4 - 1.2Rank 220/280

Key Liquidity Metrics

Quick Ratio

0.94x

Sector: 1.0 - 2.5

Current Ratio

1.18x

Sector: 1.5 - 2.5

Overall Liquidity Rank

Rank within universe#60/280

Best (1)Worst (280)

2. Valuation

Score: 211/280

Is CVSG undervalued compared to its peers and fair value metrics?

2/7

valuation criteria met

Metric

Sector Range

Value

Rank

✗

FY27e P/E

15x - 30x

11.4xRank 93/280

Range: 15x - 30xRank 93/280

✗

FY26e P/E

15x - 30x

12.4xRank 92/280

Range: 15x - 30xRank 92/280

✗

FY27e Net Div Yld (%)

1.5 - 4.5

0.82%Rank 204/280

Range: 1.5 - 4.5Rank 204/280

✓

Div Payout Ratio

30 - 60

34.00%Rank 50/280

Range: 30 - 60Rank 50/280

✗

Current EV/EBITDA

9.0x - 16.0x

8.8xRank 150/280

Range: 9.0x - 16.0xRank 150/280

–

Current P/TBV

2.0x - 7.0x

N/A

Range: 2.0x - 7.0x

✓

Current P/B

2.0x - 6.0x

2.80xRank 200/280

Range: 2.0x - 6.0xRank 200/280

Key Valuation Metrics

TTM P/E

Price-to-Earnings

48.1x

FY26e P/E

Forward estimate

12.4x

FY27e P/E

Forward estimate

11.4x

Current P/B

Price-to-Book

2.80x

Current P/TBV

Tangible Book Value

N/A

Current EV/EBITDA

Enterprise Value

8.8x

FY26e EV/EBITDA

Forward estimate

7.2x

FY27e EV/EBITDA

Forward estimate

7.2x

Dividend

CVSG pays a dividend yield of 442.11%.

Current Yield

442.11%

FY27e Net Div Yield

0.82%

FY26e Gross DPS

0.091

FY27e Gross DPS

0.096

Dividend Per Share Forecast

3. Profitability

Score: 200/280

How profitable is CVSG relative to its peers?

2/7

profitability criteria met

Metric

Sector Range

Value

Rank

✗

TTM Profit Margin

6 - 15

2.5%Rank 229/280

Range: 6 - 15Rank 229/280

✗

T12 FCF Margin

12 - 20

0.5%Rank 98/280

Range: 12 - 20Rank 98/280

✓

FY27e RoE

12 - 25

21.3%Rank 70/280

Range: 12 - 25Rank 70/280

✓

FY26 EPS Growth

8 - 15

11.1%Rank 92/280

Range: 8 - 15Rank 92/280

✗

FY27e EPS Growth

8 - 15

21.1%Rank 103/280

Range: 8 - 15Rank 103/280

–

NIM

N/A

Range: N/A

–

Expense Ratio

75 - 87

N/A

Range: 75 - 87

TTM Profit Margin

2.5%

Current RoCE

5.9%

FY27e RoE

21.3%

T12 FCF Margin

0.5%

EPS Growth

4. Solvency

Score: 191/280

How strong is CVSG's balance sheet and financial position?

0/6

solvency criteria met

Metric

Sector Range

Value

Rank

✗

Debt/Eqt

0.2x - 0.7x

1.08xRank 209/280

Range: 0.2x - 0.7xRank 209/280

–

Interest Coverage Ratio

5x - 15x

Rank 193Rank 193/280

Range: 5x - 15xRank 193/280

✗

Net Leverage Ratio

0.5x - 1.5x

1.71xRank 109/280

Range: 0.5x - 1.5xRank 109/280

–

Altman Z-Score (Manufacturing)

<1.10 - >2.60

3.30Rank 163/280

Range: <1.10 - >2.60Rank 163/280

–

Z-Score (Non Manufacturing)

<1.10 - >2.60

Rank 152Rank 152/280

Range: <1.10 - >2.60Rank 152/280

–

CapAdeq Ratio Tier1

N/A

Range: N/A

Key Solvency Metrics

Debt/Eqt

1.08x

Net Leverage Ratio

1.71x

Interest Coverage

Rank 193

T12 FCF Margin

0.5%

Altman Z-Score

3.30

Safe Zone

01.812.995+

5. Asset Efficiency

Score: 34/280

How efficiently does CVSG deploy its assets and intellectual capital?

0/5

asset efficiency criteria met

Metric

Sector Range

Value

Rank

–

Efficiency Ratio

N/A

Range: N/A

✗

TTM Asset Turnover Ratio

0.3x - 0.6x

0.97xRank 55/280

Range: 0.3x - 0.6xRank 55/280

✗

TTM CAPEX/Sales

6 - 10

5.1%Rank 87/280

Range: 6 - 10Rank 87/280

✗

Working Capital Turnover

4x - 7x

41.56xRank 10/280

Range: 4x - 7xRank 10/280

–

R&D/Sales FY27e

12 - 25

N/A

Range: 12 - 25

Overall Asset Efficiency Rank

Rank within sector peers#34/280

Best (1)Worst (280)

6. Market Trading

Score: 200/280

How liquid and actively traded is CVSG?

1/2

market trading criteria met

Metric

Sector Range

Value

Rank

✗

Intraday Sentiment (%)

30 - 60

28.0%Rank 182/280

Range: 30 - 60Rank 182/280

–

10D-Avg v/s 3M-Avg Vol

N/A

185%Rank 50/280

Range: N/ARank 50/280

✓

Avg Directional Index 30D

010 - 40

18.4Rank 160/280

Range: 010 - 40Rank 160/280

–

Parabolic SAR

N/A

1255.86Rank 76/280

Range: N/ARank 76/280

–

Stock Rating Rank

N/A

Rank 100Rank 100/280

Range: N/ARank 100/280

Market Cap

£789,867,694

Enterprise Value

£1,097,685,724

Trading Volume

7. Technical

Score: 78/280

What do the technical indicators say about CVSG?

0/5

technical criteria met

Metric

Chart

Sector Range

Value

Rank

–

CMP v/s 52-WH

£16.48£10.62

-28.8%CMP: £11.73

N/A

-28.8%Rank 246/280

£16.48£10.62

-28.8%CMP: £11.73

Range: N/ARank 246/280

–

CMP v/s 52-WL

£16.48£10.62

+10.5%CMP: £11.73

N/A

10.5%Rank 55/280

£16.48£10.62

+10.5%CMP: £11.73

Range: N/ARank 55/280

–

RSI 14D

031.2 - Bearish100

N/A

31.2Rank 50/280

031.2 - Bearish100

Range: N/ARank 50/280

–

MA50 - MA200

£12.54+0.18£12.72

N/A

BullishRank 134/280

£12.54+0.18£12.72

Range: N/ARank 134/280

–

MACD Rank

Golden Cross

MACD: -8.03

N/A

-8.03

Golden Cross

MACD: -8.03

Range: N/A

RSI (14 Day)

31.2

Bearish

0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£12.72

200 SMA£12.54

SignalGolden Cross (Bullish)

MACD-8.03

Risk Metrics

Beta

N/A

3-Yr Std Dev

N/A

5-Yr Std Dev

N/A

Peer Comparison

How does CVSG compare to other Healthcare stocks?

Overall Rank Comparison

Factor Score Comparison

Stock	Rank	Liquidity	Valuation	Profitability	Solvency	Mkt Trading	Technical
CVSG	#90	60	211	200	191	200	78
AZN.L	#4	68	242	82	111	33	248
GNS.L	#63	33	133	153	79	96	277
HIK.L	#73	52	127	186	144	180	107
CTEC.L	#115	36	182	206	147	236	211
ONT.L	#118	28	114	262	128	64	205
HLN.L	#126	71	222	169	150	240	232

Similar Stocks

Other top-ranked stocks in the Healthcare sector

Hikma Pharmaceuticals PLC

Oxford Nanopore Technologies PLC

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

Methodology Note

The analysis presented for CVS Group PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Strategyland Research Center - strategyland.ukThis report is for informational purposes only. Not financial advice.